查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1861747

冠状动脉绕道手术手术市场（依移植类型、手术类型、最终用户和应用划分）－2025-2032年全球预测

Coronary Artery Bypass Grafts Market by Graft Type, Procedure Type, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，冠状动脉绕道手术手术市场将成长至 297.6 亿美元，复合年增长率为 6.36%。

关键市场统计数据
基准年 2024 181.6亿美元
预计年份：2025年 193.2亿美元
预测年份 2032 297.6亿美元
复合年增长率 (%) 6.36%

全面概述目前冠状动脉绕道手术手术的现状，重点在于临床发展、技术应用以及对医疗服务提供者的营运影响。

本执行摘要简要介绍了现代冠状动脉绕道手术手术（CABG）的生态系统，概述了正在重塑医疗服务模式的技术、临床和营运因素。过去十年，影像学、血管获取和手术全期管理的进步改变了临床路径，而手术范围的不断扩大也带来了新的技能要求、资金规划考量和患者选择模式。

临床团队正日益努力平衡传统开放性手术与微创手术，旨在缩短恢復时间并减少资源消耗。同时，医院和专科中心也在重新思考其专案结构，以适应机器人手术、内视镜器械和专用混合手术室的引入。这些变化正在影响着各机构的人员配置模式、训练课程和资金分配决策。

此外，接受冠状动脉绕道手术的患者群体正在发生变化，人口统计学特征和合併症情况会影响移植血管的选择和手术全期策略。因此，相关人员必须整合临床证据、技术能力和操作可行性，以设计永续的治疗路径。本导言旨在引导读者检验后续章节，这些章节将探讨不断变化的现状、政策影响、细分市场资讯、区域趋势、竞争定位，并为希望改善冠状动脉绕道手术旁路移植术治疗方法的领导者提供实用建议。

快速的临床创新、外科手术多样化和供应链协作如何重塑冠状动脉再灌注治疗路径和机构优先事项

冠状动脉绕道手术手术的格局正因技术创新、器材小型化和跨学科诊疗模式的进步而改变。新兴技术正在缩小传统开放性手术与微创手术之间的差距，促使许多医疗机构重新思考临床路径，并将缩短復健时间和减少医院资源消耗作为优先事项。

同时，手术方式的多样化正在影响医疗团队建设和临床审批政策。随着微创内视镜和机器人辅助技术与非体外循环和传统体外循环技术日益普及，医疗机构面临双重挑战：既要投资于模拟培训和指导，又要维持必要的病例量以保持专业水平。这种情况促使心臟外科医师、介入性心臟科医师、麻醉师和手术全期团队之间加强合作，以优化患者预后。

供应链创新和供应商合作也正在影响科技的普及进程。製造商提供整合系统和服务模式，降低了小型专案的进入门槛，而报销环境和医院资源限制则影响技术的普及时间。同时，患者对以患者为中心的照护期望不断提高，这促使医疗机构采用循证通讯协定，以在不影响长期移植血管通畅性的前提下加速患者康復。这些因素共同作用，正在重新定义医疗机构在整个护理过程中提供冠状动脉重组手术的方式。

评估2025年美国关税变化对移植材料供应、医疗设备采购和供应链韧性的累积营运和采购影响

2025年政策和贸易发展引入的关税调整对冠状动脉绕道手术移植术相关技术的采购、製造和分销管道产生了连锁反应。这些政策措施显着影响了用于移植准备和输送系统的进口器材、专用设备和组件的成本结构，迫使许多供应链相关人员重新评估其采购和库存策略。

因此，采购团队越来越重视供应商多元化，并加强与区域製造业伙伴关係，以降低跨国政策波动带来的风险。临床负责人则与供应链负责人合作，选择临床等效的替代方案，并检验不同设备之间的互通性，以确保手术流程的连续性。同时，供应商合约谈判也日趋复杂，更加关注总体拥有成本条款、服务水准协议以及应对海关延误的方案。

在营运方面，一些医疗机构已加快对可重复使用器械的投资（在临床适用的情况下），并提高了消毒能力以抵消前置作业时间带来的风险。监管合规和品质保证团队也在供应商选择中发挥了更重要的作用，以确保替代供应商能够满足临床绩效预期。最终，贸易政策变化带来的综合影响凸显了健全的筹资策略的重要性，以及临床、供应链和商业相关人员之间密切合作的必要性。

针对性細項分析展示了移植类型、手术技术、临床环境和临床应用如何影响临床和操作决策。

細項分析揭示了不同移植类型、手术技术、终端使用者环境和应用领域所带来的独特的临床和采购影响，每种类型都有其独特的操作和实施考量。检验不同移植类型之间的差异可知，当长期通畅性是首要考虑因素时，动脉移植往往是首选的手术技术；而静脉移植则在某些特定的解剖和临床情况下占据主导地位，这会影响库存组合和外科医生培训的重点。

手术方式的多样性进一步增加了推广应用的复杂性：儘管传统心肺体外迴圈因其操作人员的广泛熟练度和可预测的工作流程，仍然是许多医疗机构的基础，但非心肺体外迴圈技术正被用于某些特定患者群体，以减轻心肺体外迴圈相关的后遗症。微创策略，包括内视镜取骨和机器人辅助手术，正在向拥有先进设备和专业围手术全期团队的中心推广，这需要对培训、模拟和手术安排进行投入。

终端使用者细分突显了门诊手术中心、心臟中心和医院之间不同的营运需求。门诊机构优先考虑吞吐量、快速復健通讯协定和精益库存管理模式，而专科心臟中心则专注于高度紧急的医疗服务组合和技术密集型手术。医院必须在承担急诊护理职责的同时兼顾广泛的外科手术病例，这需要灵活的供应合约和跨部门协作。应用主导的洞察能够区分多支血管病变和单支血管病变，从而指导临床路径设计和移植血管选择策略，因为冠状动脉解剖结构复杂的患者通常需要多学科协作和资源密集的手术全期护理。总而言之，这些细分观点指导着有针对性的专案设计和采购决策。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势正在影响招募模式、筹资策略和临床专案设计。

区域趋势将对美洲、欧洲、中东和非洲以及亚太地区的医疗程序组合、技术应用和供应链策略产生重大影响。在美洲，三级医疗中心和综合医疗保健系统尤其重视技术应用，这些机构支持资本密集技术和结构化培训计画。这种环境有利于机器人技术和混合方法的快速试点，同时要求提供严格的临床和营运效益证据。

欧洲、中东和非洲地区的区域差异导致了不同的应用模式。高所得国家的成熟心臟中心强调以结果为导向的应用，并辅以严格的法律规范；而新兴市场则优先考虑能够改善医疗服务可及性的可扩展解决方案。因此，供应商的合作策略必须进行调整，以适应报销框架、区域临床指南和基础设施能力的差异。

亚太地区心臟外科手术的普及率差异显着，多个市场正积极寻求扩大产能并推动心臟外科手术服务的现代化。製造商与当地经销商之间的策略合作对于扩大先进设备和培训的覆盖范围至关重要。在所有地区，人口趋势、冠状动脉疾病盛行率以及医疗保健系统组织结构的差异都会影响人力规划、手术方案选择和资本投资决策，因此需要针对特定市场采取临床整合和商业化策略。

设备、机器人和服务供应商之间的竞争格局和策略行动将重新定义产品差异化和临床伙伴关係。

冠状动脉绕道手术手术生态系统的竞争动态反映了老牌外科器械製造商、新兴机器人和影像处理公司以及提供全面支援的服务型供应商之间的相互作用。领先的器械製造商持续投资改善血管采集器械、吻合装置和一次性耗材，旨在简化工作流程并降低治疗结果的差异性。同时，机器人和内视镜系统正在革新传统的手术室配置，并促进技术提供者和临床中心之间就联合开发和培训计画达成合作协议。

策略差异化越来越依赖整合硬体、耗材、数据分析和教育服务的捆绑式解决方案。能够清晰展现缩短手术时间、改善病患復原指标、降低併发症发生率的供应商，正获得更高的临床认可度和偏好。同时，售后服务模式、远端监控和外科医生资格认证服务也为医院提供了竞争优势，因为医院正在寻求可预测的性能和更低的生命週期成本。

医疗设备製造商与学术机构之间的合作有助于产生证据和进行真实世界检验，这反过来又为推广应用和医保报销的讨论奠定了基础。供应链伙伴关係和区域製造地也为相关人员创造了竞争优势，尤其是有助于确保跨区域供应的连续性和快速的服务回应。

为临床和商业领导者提供切实可行的策略行动，以协调技术应用、采购弹性以及员工团队发展，从而实现专案的永续成长。

产业领导者应优先考虑分阶段、循证的技术采纳方法，使临床目标与营运能力和财务管理一致。首先，应进行多学科评估，包括手术量、外科医生培训需求和手术全期流程，以确定各机构在哪些领域投资微创或机器人手术能够带来最大的临床和营运回报。儘早与临床负责人、护理领导者和供应链合作伙伴合作，可确保制定实际的采纳时间表，并为资格认证计画提供支援。

其次，为降低营运风险，应寻求以灵活性、培训支援和按绩效付费服务协议为重点的供应商协议。如果存在关税或政策相关的采购风险，则应透过多元化采购管道和探索区域製造伙伴关係关係来提高前置作业时间可靠性。为在确保患者安全的同时加快技能提升，应投资于模拟和指导项目，并整合强大的数据收集系统，以追踪手术全期结果、资源利用情况和患者报告的康復指标。

最后，与支付方和监管机构建立合作关係，强调基于更快康復时间、更少併发症和优化治疗路径的价值提案。透过将严谨的临床实践与务实的采购和人力资源规划相结合，领导者可以以创新且能显着改善患者照护的方式，扩大先进冠状动脉重组手术的规模。

本执行摘要的调查方法以证据为导向，结合了对临床医生的访谈、监管分析、文献综述和营运案例研究，以确保提供切实可行的见解。

本执行摘要的研究基于一项多方面方法论，旨在整合临床证据、营运经验和市场情报，同时保持分析的严谨性。主要研究包括对心臟外科医生、循环系统护理师、其他医疗专业人员、采购人员和医院管理人员进行结构化访谈，以收集第一线观点对手术选择、培训限制和供应链优先事项的看法。这些定性研究结果与同行评审的临床文献、指南文件以及记录手术结果和比较技术评估的註册数据进行了三角验证。

二次分析包括监管备案和医疗设备认证讯息，以了解产品生命週期和安全性概况，以及公共文件，以解读采购和贸易趋势。此外，实地案例研究探讨了微创和机器人手术计画的推广路径及其对资源分配、人员发展和手术量的影响。品质保证措施包括对访谈主题进行交叉检验、确保资料来源的调查方法透明化，以及由临床领域专家进行同行评审，以确保解读结果反映当前的实践。

综合来看，这些方法为本摘要中提出的研究结果和建议提供了结构化的、基于证据的基础，重点在于操作适用性和临床一致性。

一篇简明扼要的综述，重点介绍冠状动脉再灌注治疗领域在技术可行性、操作可行性和供应链稳定性之间取得平衡的实用进展。

总之，冠状动脉绕道手术手术目前正处于务实演进阶段，而非全面革新。微创技术、机器人技术和手术全期手术期通讯协定的进步正在拓展治疗选择，并为改善患者体验创造机会，但培训要求、资金限制和供应链考量等组织现实因素限制变革的步伐。

政策变化和关税趋势凸显了建立稳健的采购体係以及临床和供应链部门密切合作的重要性。细分市场分析表明，移植选择、手术类型和临床环境均需根据当地的临床专长和基础设施量身定制策略。不同地区的采用模式也强调了因地制宜、使技术应用与报销体系、医疗卫生人力结构以及当地居民的医疗保健需求相契合的重要性。

对于正在经历转型期的组织而言，一条平衡的前进之路在于循序渐进的投资、严格的绩效追踪以及以服务、培训和供应连续性为重点的策略性供应商合作。透过将临床证据与营运规划结合，医疗服务提供者和产业合作伙伴既可以改善患者疗效，又能建立永续且面向未来的创新项目。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 扩大微创机器人辅助冠状动脉绕道术的应用，旨在减轻患者的身体负担和恢復时间。
  • 将先进的3D影像和扩增实境（AR）引导系统结合，以提高冠状动脉旁路移植术（CABG）的精确度。
  • 越来越多地采用混合再灌注策略，将经皮冠状动脉介入治疗与择期搭桥手术相结合，以实现最佳患者预后
  • 开发和临床应用具有更高生物相容性和长期通畅性的生物工程血管移植物
  • 透过在高风险患者群体中推广非体外迴圈冠状动脉绕道手术移植术，最大限度地减少术中併发症和发病率
  • 抗菌和抗血栓涂层移植物材料的出现旨在降低术后感染和移植物阻塞率。
  • 透过实施术后復健促进通讯协定和远端医疗监测，加快术后復健进程并降低再入院率。
  • 推广微创内视镜血管采集技术，以提高移植血管品质并减少供体部位併发症

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依移植类型冠状动脉绕道手术手术市场

  • 动脉
  • 静脉

第九章 依手术方式冠状动脉绕道手术手术市场

  • 常规泵浦上
  • 微创
    • 内视镜
    • 机器人辅助
  • 非泵送

第十章 依最终用户分類的冠状动脉绕道手术手术市场

  • 门诊手术中心
  • 心臟中心
  • 医院

第十一章 依应用分類的冠状动脉绕道手术手术市场

  • 多支血管疾病
  • 单支血管病变

第十二章冠状动脉绕道手术手术市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章冠状动脉绕道手术手术市场（按组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国冠状动脉绕道手术手术市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Terumo Corporation
    • Medtronic plc
    • Getinge AB
    • LivaNova PLC
    • Edwards Lifesciences Corporation
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Teleflex Incorporated
    • CryoLife, Inc.
    • ConMed Corporation
Product Code: MRR-2A0283E2559F

The Coronary Artery Bypass Grafts Market is projected to grow by USD 29.76 billion at a CAGR of 6.36% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 18.16 billion
Estimated Year [2025] USD 19.32 billion
Forecast Year [2032] USD 29.76 billion
CAGR (%) 6.36%

A comprehensive orientation to the current coronary artery bypass graft environment highlighting clinical evolution, technology adoption, and operational implications for providers

This executive summary opens with a concise orientation to the contemporary coronary artery bypass graft ecosystem, framing the technological, clinical, and operational forces that are reshaping care delivery. Over the past decade, advances in imaging, conduit harvesting techniques, and perioperative management have altered clinical pathways, while procedural diversification has introduced new skill requirements, capital planning considerations, and patient selection paradigms.

Clinical teams are increasingly balancing traditional open techniques with less invasive approaches that aim to reduce recovery time and resource utilization. At the same time, hospitals and specialized centers are reassessing program structures to accommodate robotics, endoscopic instrumentation, and dedicated hybrid operating rooms. These shifts have implications for staffing models, training curricula, and capital allocation decisions across institutions.

Moreover, the patient population undergoing bypass procedures is evolving, with demographic trends and comorbidity profiles influencing graft selection and perioperative strategies. As a result, stakeholders must integrate clinical evidence, technology capability, and operational feasibility to design durable care pathways. The introduction prepares the reader to explore subsequent sections that examine landscape transformations, policy impacts, segmentation intelligence, regional dynamics, competitive positioning, and pragmatic recommendations for leaders aiming to refine their approach to coronary artery bypass graft care.

How rapid clinical innovations, procedural diversification, and supply chain partnerships are reshaping coronary revascularization pathways and institutional priorities

The coronary artery bypass graft landscape is undergoing transformative shifts driven by innovations in technique, device miniaturization, and multidisciplinary care models. Emerging technologies have narrowed the gap between traditional open surgery and less invasive strategies, prompting many centers to reevaluate clinical pathways to prioritize faster recoveries and reduced inpatient resource use.

Concurrently, procedural diversification is influencing workforce development and privileging policies. As minimally invasive endoscopic and robotic-assisted techniques gain traction alongside off-pump and conventional on-pump approaches, institutions face the dual challenge of ensuring procedural volume to maintain proficiency while investing in simulation and proctoring programs. This dynamic fosters collaborative relationships between cardiac surgeons, interventional cardiologists, anesthesiologists, and perioperative teams to optimize patient outcomes.

Supply chain innovation and vendor partnerships are also affecting adoption curves. Manufacturers are offering integrated systems and service models that lower the barrier to entry for smaller programs, while reimbursement environments and hospital resource constraints shape rollout timelines. In parallel, patient-centered care expectations-driven by shorter hospital stays and quicker return-to-function-are motivating providers to adopt evidence-informed protocols that support accelerated recovery without compromising long-term graft patency. Taken together, these shifts are redefining how institutions deliver coronary revascularization across the care continuum.

Assessing the cumulative operational and procurement consequences of United States tariff shifts in 2025 on graft supplies, device sourcing, and supply chain resilience

Policy and trade dynamics in 2025 introduced tariff changes that ripple across procurement, manufacturing, and distribution channels linked to coronary artery bypass graft technologies. These policy measures have had a pronounced effect on cost structures for imported instruments, specialized devices, and component materials used in graft preparation and delivery systems, prompting many supply chain stakeholders to reassess sourcing and inventory strategies.

As a consequence, procurement teams are increasingly emphasizing supplier diversification and regional manufacturing partnerships to mitigate exposure to cross-border policy volatility. Clinical leaders have responded by working with supply chain counterparts to identify clinically equivalent alternatives and to validate device interoperability to maintain procedural continuity. In parallel, contract negotiations with vendors have grown more intricate, with greater focus on total-cost-of-ownership clauses, service level agreements, and contingencies for customs-related delays.

Operationally, some institutions have accelerated investments in reusable instrumentation where clinically appropriate and enhanced sterilization capacity to offset lead-time risks. Regulatory compliance and quality assurance teams have also become more central to vendor selection, ensuring that alternative sources meet clinical performance expectations. Ultimately, the combined effect of trade policy shifts has underscored the importance of resilient procurement strategies and closer alignment between clinical, supply chain, and commercial stakeholders.

Targeted segmentation insights showing how graft type, procedure modality, care setting, and clinical application drive distinct clinical and operational decisions

Segmentation-based insights reveal differentiated clinical and procurement implications across graft types, procedure modalities, end-user settings, and applications, each carrying distinct operational and adoption considerations. When examining graft type distinctions, arterial conduits often command procedural preference where long-term patency is prioritized, whereas venous grafts remain a mainstay for specific anatomic and clinical scenarios, influencing inventory mix and surgeon training priorities.

Procedure type distinctions further nuance adoption pathways: conventional on-pump approaches anchor many institutional programs due to broad practitioner familiarity and predictable workflows, while off-pump techniques are leveraged in select populations to reduce cardiopulmonary bypass-related sequelae. Minimally invasive strategies, including endoscopic harvesting and robotic-assisted operations, are expanding into centers that can support advanced instrumentation and dedicated perioperative teams, and they necessitate coordinated investments in training, simulation, and case scheduling.

End-user segmentation underscores divergent operational requirements across ambulatory surgical centers, cardiac centers, and hospitals. Ambulatory facilities emphasize throughput, rapid recovery protocols, and lean inventory models, whereas specialized cardiac centers focus on high-acuity service portfolios and technology-intensive procedures. Hospitals balance both acute care responsibilities and broader surgical case mixes, requiring flexible supply agreements and cross-departmental coordination. Application-driven insights, differentiating multi-vessel disease from single-vessel disease, inform clinical pathway design and graft selection strategies, as patients with complex coronary anatomy often demand multi-disciplinary planning and resource-intensive perioperative care. These segmentation perspectives collectively guide targeted program design and procurement decisions.

Regional dynamics across the Americas, Europe Middle East and Africa, and Asia-Pacific that influence adoption patterns, procurement strategies, and clinical program design

Regional dynamics exert a strong influence on procedural mix, technology adoption, and supply chain strategies across the Americas, Europe Middle East and Africa, and Asia-Pacific geographies. In the Americas, there is a pronounced emphasis on innovation diffusion within tertiary centers and integrated health systems that can underwrite capital-intensive technologies and structured training programs. This environment supports rapid piloting of robotics and hybrid approaches while demanding rigorous evidence of clinical and operational benefit.

Across Europe, the Middle East and Africa, regional heterogeneity leads to varied adoption profiles; established cardiac centers in high-income countries emphasize outcomes-driven implementation with strong regulatory oversight, whereas emerging markets prioritize scalable solutions that improve access to care. Consequently, vendor engagement strategies must be adapted to account for reimbursement frameworks, local clinical guidelines, and variable infrastructure capabilities.

The Asia-Pacific region displays a broad spectrum of adoption velocities, with several markets actively pursuing capacity expansion and modernization of cardiac surgical services. Strategic partnerships between manufacturers and regional distributors have been pivotal in expanding access to advanced instruments and training. Across all regions, differences in demographic trends, prevalence of coronary disease, and health system organization shape workforce planning, procedural selection, and capital investment decisions, requiring market-specific approaches to clinical integration and commercialization.

Competitive landscape and strategic behaviors among device, robotics, and service providers that are redefining product differentiation and clinical partnerships

Competitive dynamics in the coronary artery bypass graft ecosystem reflect an interplay between established surgical device manufacturers, emerging robotics and imaging companies, and service-oriented vendors offering integrated support. Leading device firms continue to invest in iterative improvements to conduit harvesting tools, anastomotic devices, and disposables that aim to simplify workflows and reduce variability in outcomes. At the same time, robotics and endoscopic systems are disrupting traditional operating room configurations, prompting collaborative agreements between tech providers and clinical centers for co-development and training programs.

Strategic differentiation increasingly rests on bundled solutions that combine hardware, consumables, data analytics, and educational services. Vendors that demonstrate a clear pathway to reduce operating time, improve patient recovery metrics, or lower complication rates secure stronger clinical advocacy and preference. Meanwhile, aftermarket service models, remote monitoring, and surgeon credentialing offerings have become competitive levers as hospitals seek predictable performance and reduced lifecycle costs.

Partnerships between device manufacturers and academic centers facilitate evidence generation and real-world validation, which in turn informs adoption and reimbursement conversations. Supply chain partnerships and regional manufacturing footprints are also shaping competitive positioning, particularly for stakeholders aiming to ensure continuity of supply and responsive service across diverse geographies.

Practical strategic actions for clinical and commercial leaders to align technology adoption, procurement resilience, and workforce development for sustainable program growth

Industry leaders should prioritize a phased, evidence-driven approach to technology adoption that aligns clinical objectives with operational capacity and financial stewardship. Begin by conducting multidisciplinary assessments of procedure volumes, surgeon training needs, and perioperative pathways to identify which minimally invasive or robotic investments will yield the greatest clinical and operational returns for a given institution. Early engagement with clinical champions, nursing leadership, and supply chain partners ensures realistic implementation timelines and supports credentialing plans.

Next, pursue supplier agreements that emphasize flexibility, training support, and outcome-linked service commitments to mitigate operational risk. Where tariff- or policy-related procurement exposures exist, diversify sourcing and consider regional manufacturing partnerships to improve lead-time reliability. Invest in simulation and proctoring programs to accelerate proficiency while protecting patient safety, and integrate robust data collection to track perioperative outcomes, resource use, and patient-reported recovery metrics.

Finally, foster collaborative relationships with payers and regulatory stakeholders to highlight value propositions rooted in improved recovery times, reduced complications, and optimized care pathways. By combining clinical rigor with pragmatic procurement and workforce planning, leaders can scale advanced coronary revascularization approaches in a manner that balances innovation with measurable improvements in patient care.

An evidence-driven research methodology combining primary clinician interviews, regulatory analysis, literature review, and operational case studies to ensure actionable insights

The research underpinning this executive summary draws on a multi-method approach designed to synthesize clinical evidence, operational experience, and market intelligence while preserving analytical rigor. Primary research involved structured interviews with cardiac surgeons, perfusionists, allied health professionals, procurement directors, and hospital administrators to capture firsthand perspectives on procedural selection, training constraints, and supply chain priorities. These qualitative insights were triangulated with peer-reviewed clinical literature, guideline documents, and registries that document procedural outcomes and comparative technique evaluations.

Secondary analysis incorporated regulatory filings and device approvals to understand product lifecycles and safety profiles, alongside public policy materials that contextualize procurement and trade dynamics. Additionally, site-level case studies explored implementation pathways for minimally invasive and robotic programs, highlighting resource allocation, staff competency development, and throughput impacts. Quality assurance measures included cross-validation of interview themes, methodological transparency regarding data sources, and peer review by clinical subject-matter experts to ensure that interpretations reflect current practice realities.

Together, these methods provide a structured, evidence-informed basis for the insights and recommendations offered in this summary, with an emphasis on operational applicability and clinical integrity.

A concise synthesis emphasizing pragmatic evolution in coronary revascularization balancing technological promise with operational feasibility and supply chain stability

In conclusion, the coronary artery bypass graft environment is in a period of pragmatic evolution rather than wholesale replacement. Advances in minimally invasive techniques, robotics, and perioperative protocols are expanding therapeutic options and creating opportunities for improved patient experiences, while institutional realities such as training requirements, capital constraints, and supply chain considerations temper the pace of change.

Policy shifts and tariff dynamics have highlighted the importance of procurement resilience and closer collaboration between clinical and supply chain leadership. Segmentation insights demonstrate that graft selection, procedural modality, and care setting each demand tailored strategies that accommodate local clinical expertise and infrastructure. Regionally, diverse adoption patterns underscore the value of context-specific approaches that align technology deployment with reimbursement, workforce capacity, and population health needs.

For organizations seeking to navigate this transition, the balanced path forward involves phased investment, rigorous outcome tracking, and strategic supplier partnerships that emphasize service, training, and supply continuity. By synthesizing clinical evidence with operational planning, providers and industry partners can improve patient outcomes while building programs that are sustainable and responsive to future innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of minimally invasive robotic-assisted coronary artery bypass procedures to reduce patient trauma and recovery times
  • 5.2. Integration of advanced 3D imaging and augmented reality guidance systems for enhanced surgical precision in CABG operations
  • 5.3. Rising utilization of hybrid revascularization strategies combining percutaneous coronary interventions with selective bypass grafting for optimal patient outcomes
  • 5.4. Development and clinical adoption of bioengineered vascular grafts with improved biocompatibility and long-term patency rates
  • 5.5. Expansion of off-pump coronary artery bypass techniques in high-risk patient populations to minimize intraoperative complications and morbidity
  • 5.6. Emergence of antimicrobial and antithrombotic-coated graft materials aimed at reducing postoperative infections and graft occlusion rates
  • 5.7. Implementation of enhanced recovery after surgery protocols and telehealth monitoring to accelerate postoperative rehabilitation and reduce readmission
  • 5.8. Growth of minimally invasive endoscopic vessel harvesting methods to improve graft quality and decrease donor site complications

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Artery Bypass Grafts Market, by Graft Type

  • 8.1. Arterial
  • 8.2. Venous

9. Coronary Artery Bypass Grafts Market, by Procedure Type

  • 9.1. Conventional On Pump
  • 9.2. Minimally Invasive
    • 9.2.1. Endoscopic
    • 9.2.2. Robotic
  • 9.3. Off Pump

10. Coronary Artery Bypass Grafts Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Centers
  • 10.3. Hospitals

11. Coronary Artery Bypass Grafts Market, by Application

  • 11.1. Multi Vessel Disease
  • 11.2. Single Vessel Disease

12. Coronary Artery Bypass Grafts Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Coronary Artery Bypass Grafts Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Coronary Artery Bypass Grafts Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Terumo Corporation
    • 15.3.2. Medtronic plc
    • 15.3.3. Getinge AB
    • 15.3.4. LivaNova PLC
    • 15.3.5. Edwards Lifesciences Corporation
    • 15.3.6. B. Braun Melsungen AG
    • 15.3.7. Baxter International Inc.
    • 15.3.8. Teleflex Incorporated
    • 15.3.9. CryoLife, Inc.
    • 15.3.10. ConMed Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CORONARY ARTERY BYPASS GRAFTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CORONARY ARTERY BYPASS GRAFTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CORONARY ARTERY BYPASS GRAFTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ARTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY VENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CONVENTIONAL ON PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY OFF PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MULTI VESSEL DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SINGLE VESSEL DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 91. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 93. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 95. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 97. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 99. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 108. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. NORTH AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 120. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. LATIN AMERICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 156. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. MIDDLE EAST CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 168. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 169. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. AFRICA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 194. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 195. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. ASEAN CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 199. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 206. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 207. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. GCC CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 230. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 231. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. BRICS CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 242. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 243. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. G7 CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 254. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 255. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. NATO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 267. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED STATES CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 276. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 277. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. CANADA CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 286. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 287. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. MEXICO CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 296. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 297. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. BRAZIL CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY MINIMALLY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM CORONARY ARTERY BYPASS GRAFTS MARKET S